Largecap News Today — October 22, 2026

The markets continue to navigate a complex landscape, with investors weighing the potential of emerging technologies against traditional financial realities. A warning from a top strategist is out today, cautioning retail investors who are chasing the AI rally, suggesting that they may be getting in over their heads. This comes as companies like Tesla and Meta are making headlines, with Tesla reporting better-than-expected earnings and sales, despite a decline in auto revenue, and its stock, along with Meta's, getting a boost from optimism surrounding SpaceX's financial performance.

Meanwhile, individual investors and consumers are dealing with their own financial decisions, as illustrated by the example of an 81-year-old man who sold his home and paid off his daughter's debt, raising questions about the implications for his financial security going forward. In the biotech space, Moderna is on the verge of releasing trial results for its cancer vaccine, which could have significant implications for the company's future prospects. And in a potentially transformative move, there is speculation about a merger between Tesla and SpaceX, although some investors are being advised to approach such a deal with skepticism. These stories highlight the varied and often competing forces at play in the markets today.

Today's signal:
• A top strategist has a warning for retail investors chasing the AI rally (marketwatch.com)
• My father-in-law, 81, sold his $75,000 home and paid off his daughter’s $50,000 debt. What happens to him now? (marketwatch.com)
• Why investors should be skeptical of a potential Tesla-SpaceX merger (marketwatch.com)
• Tesla beats on earnings and sales even as auto revenue declines (cnbc.com)
• Meta and Tesla bulls get confidence boost after SpaceX earnings (cnbc.com)
• Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data. (marketwatch.com)